Overview

Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone

Status:
Suspended
Trial end date:
2021-08-01
Target enrollment:
0
Participant gender:
All
Summary
The clinical trial is a randomized control trial to compare the efficacy of a combined lidocaine and corticosteroid (CS) injection versus a corticosteroid injection (CS) alone on pain, range of motion, and patient reported outcomes for the treatment of common upper extremity tendinopathies and nerve entrapments that are often treated with a combination of these injectates.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Emory University
Treatments:
Lidocaine
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Criteria
Inclusion Criteria:

- All adult clinical patients of Emory upper extremity surgeons undergoing injection for
treatment of the following who are willing to participate in the study will be
included in the study: Tenosynovitis of the upper extremity, including but not limited
to, the shoulder, biceps, elbow, wrist, thumb, carpometacarpal, midcarpal, elbow, and
small joints of the hand.

- Between the ages of 18 years and 95 years.

- For trigger finger: patients with a diagnosis of stenosing tenosynovitis based on a
history of triggering and the presence of tenderness over the A1 pulley upon clinical
examination. All patients, based on the Quinnell grading of trigger finger will be
included.

Exclusion Criteria:

- Patients who are minors, vulnerable subjects, or who are not willing to consent to
participate in the study.

- Allergies to glucocorticoids, current daily use of glucocorticoids or strong opioids
(morphine, fentanyl, hydromorphone, ketobemidone, methadone, nicomorphine, oxycodone,
and meperidine), severe diabetic neuropathy of the hand influencing pain perception,
rheumatoid arthritis, and neurological or psychiatric diseases, potentially
influencing pain perception.

- Subjects who, in the opinion of the investigator, may be non-compliant with study
schedules or procedures.